Accolade Stock Forecast, Price & News

+0.44 (+0.82 %)
(As of 06/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume352,534 shs
Average Volume505,602 shs
Market Capitalization$3.16 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ACCD News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

Accolade logo

About Accolade

Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.59 out of 5 stars

Business Services Sector

123rd out of 505 stocks

Business Services, Not Elsewhere Classified Industry

52nd out of 203 stocks

Analyst Opinion: 2.5Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Accolade (NASDAQ:ACCD) Frequently Asked Questions

Is Accolade a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Accolade stock.
View analyst ratings for Accolade
or view top-rated stocks.

What stocks does MarketBeat like better than Accolade?

Wall Street analysts have given Accolade a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Accolade wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Accolade's next earnings date?

Accolade is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for Accolade

How were Accolade's earnings last quarter?

Accolade, Inc. (NASDAQ:ACCD) posted its earnings results on Tuesday, May, 4th. The company reported ($0.22) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.12. The business earned $59.23 million during the quarter, compared to the consensus estimate of $55.38 million. Accolade had a negative net margin of 29.73% and a negative trailing twelve-month return on equity of 27.59%. The company's revenue was up 33.3% on a year-over-year basis.
View Accolade's earnings history

What guidance has Accolade issued on next quarter's earnings?

Accolade issued an update on its first quarter 2022 earnings guidance on Wednesday, May, 26th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $54 million-$56 million, compared to the consensus revenue estimate of $53.43 million.

What price target have analysts set for ACCD?

12 equities research analysts have issued 12-month price targets for Accolade's stock. Their forecasts range from $39.00 to $62.00. On average, they anticipate Accolade's share price to reach $54.92 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Accolade
or view top-rated stocks among Wall Street analysts.

Who are Accolade's key executives?

Accolade's management team includes the following people:
  • Mr. Rajeev Singh, Chairman & CEO (Age 52, Pay $743k)
  • Mr. Robert Cavanaugh, Pres (Age 52, Pay $640.5k)
  • Mr. Stephen H. Barnes, CFO, Treasurer & Sec. (Age 50, Pay $561k)
  • Mr. Phong Nguyen, Chief Operating Officer
  • Mr. Harish Naidu, Chief Technology Officer
  • Mr. Todd Friedman, Sr. VP of Investor Relations
  • Mr. Richard Eskew, Exec. VP, Gen. Counsel & Chief Privacy Officer
  • Mr. William S. Morrison, Sr. VP of Strategy & Corp. Devel.
  • Ms. Britt Provost, Exec. VP of People & Culture
  • Ms. Donna Snow, Sr. VP of Clinical Solutions

What is Rajeev Singh's approval rating as Accolade's CEO?

152 employees have rated Accolade CEO Rajeev Singh on Rajeev Singh has an approval rating of 74% among Accolade's employees.

Who are some of Accolade's key competitors?

What other stocks do shareholders of Accolade own?

When did Accolade IPO?

(ACCD) raised $176 million in an initial public offering (IPO) on Thursday, July 2nd 2020. The company issued 8,800,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

What is Accolade's stock symbol?

Accolade trades on the NASDAQ under the ticker symbol "ACCD."

Who are Accolade's major shareholders?

Accolade's stock is owned by a variety of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (9.05%), Select Equity Group L.P. (3.47%), BlackRock Inc. (3.47%), Gilder Gagnon Howe & Co. LLC (3.23%), JPMorgan Chase & Co. (3.01%) and Bellevue Group AG (2.81%).
View institutional ownership trends for Accolade

Which major investors are selling Accolade stock?

ACCD stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Ameriprise Financial Inc., JPMorgan Chase & Co., Eaton Vance Management, Provenire Capital LLC, Quantbot Technologies LP, Bank of Montreal Can, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Accolade
or view top insider-selling stocks.

Which major investors are buying Accolade stock?

ACCD stock was purchased by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, University of Texas Texas AM Investment Managment Co., Bellevue Group AG, Select Equity Group L.P., BlackRock Inc., Sectoral Asset Management Inc, Blackstone Group Inc., and Blackstone Group Inc..
View insider buying and selling activity for Accolade
or or view top insider-buying stocks.

How do I buy shares of Accolade?

Shares of ACCD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Accolade's stock price today?

One share of ACCD stock can currently be purchased for approximately $53.88.

How much money does Accolade make?

Accolade has a market capitalization of $3.16 billion and generates $170.36 million in revenue each year. The company earns $-50,650,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis.

How many employees does Accolade have?

Accolade employs 1,720 workers across the globe.

What is Accolade's official website?

The official website for Accolade is

Where are Accolade's headquarters?

Accolade is headquartered at 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462.

How can I contact Accolade?

Accolade's mailing address is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. The company can be reached via phone at 347-574-3820 or via email at [email protected]

This page was last updated on 6/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.